Current Report Filing (8-k)
December 13 2022 - 07:04AM
Edgar (US Regulatory)
0000059478false00000594782022-12-132022-12-130000059478us-gaap:CommonClassAMember2022-12-132022-12-130000059478lly:A718NotesDueJune12025Member2022-12-132022-12-130000059478lly:A1.625NotesDueJune22026Member2022-12-132022-12-130000059478lly:A2.125NotesDueJune32030Member2022-12-132022-12-130000059478lly:A625Notesdue2031Member2022-12-132022-12-130000059478lly:A500NotesDue2033Member2022-12-132022-12-130000059478lly:A6.77NotesDueJanuary12036Member2022-12-132022-12-130000059478lly:A1625NotesDue2043Member2022-12-132022-12-130000059478lly:A1.700Notesdue2049Member2022-12-132022-12-130000059478lly:A1125NotesDue2051Member2022-12-132022-12-130000059478lly:A1375NotesDue2061Member2022-12-132022-12-13
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 13,
2022
ELI LILLY AND COMPANY
(Exact Name of Registrant as Specified in its
Charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indiana |
|
001-06351 |
|
35-0470950 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lilly Corporate Center |
|
|
|
|
Indianapolis, |
Indiana |
46285 |
|
|
|
(Address of Principal Executive Offices) |
(Zip Code) |
|
Registrant’s Telephone Number, Including Area Code: (317)
276-2000
Not Applicable
(Former Name or Former Address, if Changed Since Last
Report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see
General Instruction A.2.):
|
|
|
|
|
|
|
|
|
|
☐ |
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
|
|
|
|
|
|
|
|
☐ |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
|
|
|
|
|
|
|
|
☐ |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
|
|
|
|
|
|
☐ |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
Common Stock (no par value) |
|
LLY |
|
New York Stock Exchange |
|
7 1/8% Notes due 2025 |
|
LLY25 |
|
New York Stock Exchange |
|
1.625% Notes due 2026 |
|
LLY26 |
|
New York Stock Exchange |
|
2.125% Notes due 2030 |
|
LLY30 |
|
New York Stock Exchange |
|
0.625% Notes due 2031 |
|
LLY31 |
|
New York Stock Exchange |
|
0.500% Notes due 2033 |
|
LLY33 |
|
New York Stock Exchange |
|
6.77% Notes due 2036 |
|
LLY36 |
|
New York Stock Exchange |
|
1.625% Notes due 2043 |
|
LLY43 |
|
New York Stock Exchange |
|
1.700% Notes due 2049 |
|
LLY49A |
|
New York Stock Exchange |
|
1.125% Notes due 2051 |
|
LLY51 |
|
New York Stock Exchange |
|
1.375% Notes due 2061 |
|
LLY61 |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17
CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR §240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 2.02. Results of Operations and Financial
Condition.
On December 13, 2022, Eli Lilly and Company (the “Company”) issued
a press release announcing its financial guidance for 2023. In
addition, on the same day, the Company held a teleconference for
analysts and media to discuss this guidance. The teleconference was
webcast on the Company’s website. The press release is attached to
this Form 8-K as Exhibit 99.1.
The information in this Item 2.02, including Exhibit 99.1 attached
hereto, is being furnished and shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or otherwise subject to the
liabilities of that Section and shall not be deemed incorporated by
reference into any registration statement or other document
pursuant to the Securities Act of 1933, as amended, or the Exchange
Act, except as otherwise expressly stated in such
filing.
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits
|
|
|
|
|
|
|
Exhibit No. |
Description |
|
|
|
|
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL
document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
ELI LILLY AND COMPANY |
|
(Registrant) |
|
|
|
By: |
|
/s/ Donald A. Zakrowski |
|
Name: |
|
Donald A. Zakrowski |
|
Title: |
|
Senior Vice President, Finance, and
Chief Accounting Officer |
|
Date: |
|
December 13, 2022 |
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2023 to Mar 2023
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2022 to Mar 2023
